Cargando…
Atypical responses to neoadjuvant chemotherapy combined with accelerated partial breast tumor-directed radiotherapy: two cases and considerations for future clinical trials
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Via Medica
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826652/ https://www.ncbi.nlm.nih.gov/pubmed/36632297 http://dx.doi.org/10.5603/RPOR.a2022.0112 |
| _version_ | 1784866903367352320 |
|---|---|
| author | To, Nhu Hanh Kossai, Myriam Ouidir, Nabila Grellier, Noemie Assaf, Elias Gabelle-Flandin, Isabelle Belkacemi, Yazid Radosevic-Robin, Nina |
| author_facet | To, Nhu Hanh Kossai, Myriam Ouidir, Nabila Grellier, Noemie Assaf, Elias Gabelle-Flandin, Isabelle Belkacemi, Yazid Radosevic-Robin, Nina |
| author_sort | To, Nhu Hanh |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9826652 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Via Medica |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98266522023-01-10 Atypical responses to neoadjuvant chemotherapy combined with accelerated partial breast tumor-directed radiotherapy: two cases and considerations for future clinical trials To, Nhu Hanh Kossai, Myriam Ouidir, Nabila Grellier, Noemie Assaf, Elias Gabelle-Flandin, Isabelle Belkacemi, Yazid Radosevic-Robin, Nina Rep Pract Oncol Radiother Clinical Vignette Via Medica 2022-12-29 /pmc/articles/PMC9826652/ /pubmed/36632297 http://dx.doi.org/10.5603/RPOR.a2022.0112 Text en © 2022 Greater Poland Cancer Centre https://creativecommons.org/licenses/by-nc-nd/4.0/This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially |
| spellingShingle | Clinical Vignette To, Nhu Hanh Kossai, Myriam Ouidir, Nabila Grellier, Noemie Assaf, Elias Gabelle-Flandin, Isabelle Belkacemi, Yazid Radosevic-Robin, Nina Atypical responses to neoadjuvant chemotherapy combined with accelerated partial breast tumor-directed radiotherapy: two cases and considerations for future clinical trials |
| title | Atypical responses to neoadjuvant chemotherapy combined with accelerated partial breast tumor-directed radiotherapy: two cases and considerations for future clinical trials |
| title_full | Atypical responses to neoadjuvant chemotherapy combined with accelerated partial breast tumor-directed radiotherapy: two cases and considerations for future clinical trials |
| title_fullStr | Atypical responses to neoadjuvant chemotherapy combined with accelerated partial breast tumor-directed radiotherapy: two cases and considerations for future clinical trials |
| title_full_unstemmed | Atypical responses to neoadjuvant chemotherapy combined with accelerated partial breast tumor-directed radiotherapy: two cases and considerations for future clinical trials |
| title_short | Atypical responses to neoadjuvant chemotherapy combined with accelerated partial breast tumor-directed radiotherapy: two cases and considerations for future clinical trials |
| title_sort | atypical responses to neoadjuvant chemotherapy combined with accelerated partial breast tumor-directed radiotherapy: two cases and considerations for future clinical trials |
| topic | Clinical Vignette |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826652/ https://www.ncbi.nlm.nih.gov/pubmed/36632297 http://dx.doi.org/10.5603/RPOR.a2022.0112 |
| work_keys_str_mv | AT tonhuhanh atypicalresponsestoneoadjuvantchemotherapycombinedwithacceleratedpartialbreasttumordirectedradiotherapytwocasesandconsiderationsforfutureclinicaltrials AT kossaimyriam atypicalresponsestoneoadjuvantchemotherapycombinedwithacceleratedpartialbreasttumordirectedradiotherapytwocasesandconsiderationsforfutureclinicaltrials AT ouidirnabila atypicalresponsestoneoadjuvantchemotherapycombinedwithacceleratedpartialbreasttumordirectedradiotherapytwocasesandconsiderationsforfutureclinicaltrials AT grelliernoemie atypicalresponsestoneoadjuvantchemotherapycombinedwithacceleratedpartialbreasttumordirectedradiotherapytwocasesandconsiderationsforfutureclinicaltrials AT assafelias atypicalresponsestoneoadjuvantchemotherapycombinedwithacceleratedpartialbreasttumordirectedradiotherapytwocasesandconsiderationsforfutureclinicaltrials AT gabelleflandinisabelle atypicalresponsestoneoadjuvantchemotherapycombinedwithacceleratedpartialbreasttumordirectedradiotherapytwocasesandconsiderationsforfutureclinicaltrials AT belkacemiyazid atypicalresponsestoneoadjuvantchemotherapycombinedwithacceleratedpartialbreasttumordirectedradiotherapytwocasesandconsiderationsforfutureclinicaltrials AT radosevicrobinnina atypicalresponsestoneoadjuvantchemotherapycombinedwithacceleratedpartialbreasttumordirectedradiotherapytwocasesandconsiderationsforfutureclinicaltrials |